Sustained elevation of the level of serum thyrotropin (TSH), induced by goitrogen administration, leads to three phases of thyroid growth in the rat (Philp et al., 1969; WynfordThomas et al., 1982b ). An initial 1-2 month period of rapid proliferation of follicular and stromal cells is followed by a long plateau during which little or no growth occurs until finally after 6-12 months, follicular cell tumours begin to appear (Griesbach et al., 1945; Purves & Griesbach 1947) .
Previous studies (Wynford-Thomas et al., 1982a, b, c, d ) concentrating on the pre-neoplastic period have shown that limitation of thyroid growth prior to tumour formation is due to a specific desensitisation of the follicular cell to the mitogenic action of TSH and suggest that the emergence of tumours is due to a failure of this control mechanism.
During the course of this work we observed that early tumours appeared to show an increase in vascularity, suggesting that the neoplastic follicular cell might have a trophic influence on capillaries. This study was therefore designed to quantify the vascular changes which occur in the early stages of TSH-induced thyroid neoplasia.
Ten male Wistar rats, aged between 10 and 11 weeks, and weighing 195+12g, were fed a standard laboratory diet (Pilsbury's modified rat and mouse breeding diet, iodine content 600pgkg-1), together with the goitrogen aminotriazole (ATA) in the drinking water at a concentration of 0.1%. This regimen had been previously shown to suppress all detectable thyroid hormone synthesis and to give a sustained elevation of serum TSH (Stringer et al., 1981) . Half the animals were treated for 7 months, the remainder for 1 year.
At sacrifice, anaesthesia was induced with urethane (16.8 mmol kg-') i.p., and perfusionfixation carried out via the aorta at a pressure (95mm/Hg) equal to that employed by Zeligs & Wollman (1976) . The fixative consisted of a mixture of 1% formaldehyde and 2.5% glutaraldehyde as described previously (Stringer et al., 1982 (Vv) was estimated by a systematic "point-counting" method (Weibel et al., 1966 (Weibel, 1979a) profiles, d, from which D is given by:
D =d/(1-0.21d) (Abercrombie, 1946) The number of endothelial nuclear profiles contained within a square field of area 0.09mm2 was determined. From this number per unit area, NA, was calculated. The number per mm3, (NV), is related to NA as follows (Weibel, 1979b) where t = section thickness D was obtained separately by measuring the length of 100 randomly chosen nuclear profiles parallel to an eyepiece scale using a x 63 objective. This gives the observed mean tangent diameter of The number of nuclei was assumed to be equal to the number of cells. Endothelial cell number per unit surface area of endothelium (Ns) was given by the ratio NV/SV.
Mean body weights (±s.e.) after 7 and 12 months of ATA treatment were 526 + 52 g and 652 + 38 g respectively. The corresponding thyroid weights were 344 + 71 mg and 435 + 65 mg.
Three tumours were found in the animals killed at 7 months all occurring in the same rat. Sixteen tumours were found in 4 out of the 5 animals at 12 months. All were multiple; the majority were <0.5mm in diameter.
Most of the tumours ( Figure 1 ) were well-defined adenomas consisting of groups of follicles surrounded by a pseudo-capsule of compressed al., 1982b) . Endothelial cell mitoses were seen in several tumours (although with a lower frequency than that for follicular cells), but were not seen in the background thyroid.
The most striking feature of these tumours, however, was their vasculature. In all but a few cases, the follicles were surrounded by greatly enlarged vascular spaces lined by endothelium and almost certainly representing dilated capillaries, the diameter of which sometimes exceeded that of the follicles. A small number of tumours in the 12-month group consisted of unusually large follicles, and did not show particularly prominent vasculature.
Capillary V, was significantly higher than background in 13/19 tumours, and in only 2 was it lower than the background (Table I Our results show that, as expected, long-term elevation of serum TSH, induced by ATA administration led to a high incidence of benign follicular cell tumours by one year. The striking increase in vascularity seen in our tumours seems to have been infrequently observed in the past, most studies having shown inconspicuous tumour vasculature (Griesbach et al., 1945; Purves & Griesbach 1947; Wollman 1961; Tsuda et al., 1976) . Money & Rawson (1950) briefly referred to the presence of "dilated blood sinuses", which they suggested might be the cause of haemorrhage in thyroid adenomas, and Lindsay et al. (1966) observed dilated sinuses in tumours induced by propylthiouracil. The only detailed account, however, is that of Axelrad & Leblond (1955) , who noted that the earliest tumours occurring in rats maintained on a low iodine diet for up to a year contained "large blood-filled sinuses"; their "#1 nodules" appear to have been identical to the majority of our tumours.
Standard immersion fixation of the thyroid results in collapse of capillaries and the increase.in proportional volume of blood vessels during thyroid (Wollman et al., 1978; Wynford-Thomas et al., 1982d) . This study demonstrates that in comparison with the background hyperplastic gland, early TSHinduced thyroid tumours show a highly significant increase in the proportional volume occupied by capillaries, and a marked (7.5-fold) increase in the cross-sectional area of these vessels. As this increase in calibre is not accomplished by a fall in endothelial cell density per unit of capillary surface, it is not due to elongation of the existing endothelial cells, either in vivo, or artefactually, during perfusion.
The major vascular changes we see in the tumours as compared to the hyperplastic gland from which they have arisen is that the vascular volume is increased, and the size of the individual capillary profile is very greatly increased, while the density of endothelial cells in the capillary wall is unaltered. These changes are extensions of the changes seen during the process of hyperplasia (Wynford-Thomas et al., 1982d; Wollman et al., 1978) . We have shown that the follicular cells become desensitized to the growth stimulating but not the function stimulating effect of TSH during prolonged goitrogen treatment, and believe that the early tumours that follow prolonged elevation of TSH are the result of a loss of this desensitization (Wynford-Thomas et al., 1982a, b) . The mechanism inducing the vascular changes in thyroid tumours may well be the same as that leading to vascular changes in the physiological hyperplasia of the thyroid induced by TSH. The changes are not related solely to the follicular cell number, as there is a marked regression of vascular changes, with loss of endothelial cells, following goitrogen withdrawal, even though follicular cell number does not change significantly. (Santler, 1957; WynfordThomas et al., 1982c) .
There seems therefore no need to postulate that any tumour-specific angiogenesis factor is produced by these thyroid tumours. Normal tissues have been shown to produce angiogenesis factors (Ausbrunck, 1979) and we believe that the most likely explanation of the vascular changes in thyroid hyperplasia and tumour formation is that they are both dependent on a factor produced by stimulated thyroid follicular cells D.W.-T. is a Wellcome Research Fellow.
